Atea Pharmaceuticals Stock Market Value
| AVIR Stock | USD 2.97 0.05 1.71% |
| Symbol | Atea |
Atea Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea Pharmaceuticals. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (2.11) | Revenue Per Share | Quarterly Revenue Growth 2.952 | Return On Assets |
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Atea Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Atea Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Atea Pharmaceuticals.
| 01/06/2025 |
| 02/05/2025 |
If you would invest 0.00 in Atea Pharmaceuticals on January 6, 2025 and sell it all today you would earn a total of 0.00 from holding Atea Pharmaceuticals or generate 0.0% return on investment in Atea Pharmaceuticals over 30 days. Atea Pharmaceuticals is related to or competes with Immix Biopharma, Hepion Pharmaceuticals, Enveric Biosciences, Elevation Oncology, and Ocean Biomedical. Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commerci... More
Atea Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Atea Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Atea Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 16.89 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 4.85 |
Atea Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atea Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Atea Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Atea Pharmaceuticals historical prices to predict the future Atea Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (34.07) |
Atea Pharmaceuticals Backtested Returns
Atea Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0762, which signifies that the company had a -0.0762 % return per unit of standard deviation over the last 3 months. Atea Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Atea Pharmaceuticals' mean deviation of 2.11, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.005, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Atea Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Atea Pharmaceuticals is expected to be smaller as well. At this point, Atea Pharmaceuticals has a negative expected return of -0.21%. Please make sure to confirm Atea Pharmaceuticals' skewness, and the relationship between the total risk alpha and day median price , to decide if Atea Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.16 |
Very weak predictability
Atea Pharmaceuticals has very weak predictability. Overlapping area represents the amount of predictability between Atea Pharmaceuticals time series from 6th of January 2025 to 21st of January 2025 and 21st of January 2025 to 5th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Atea Pharmaceuticals price movement. The serial correlation of 0.16 indicates that over 16.0% of current Atea Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Atea Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Atea Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Atea Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Atea Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Atea Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Atea Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Atea Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Atea Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Atea Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Atea Pharmaceuticals Lagged Returns
When evaluating Atea Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Atea Pharmaceuticals stock have on its future price. Atea Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Atea Pharmaceuticals autocorrelation shows the relationship between Atea Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Atea Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Atea Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Atea Stock
The ability to find closely correlated positions to Atea Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea Pharmaceuticals to buy it.
The correlation of Atea Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Atea Stock Analysis
When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.